| 3 E Network Outlines Planned Use of $5.0 Million Private Placement Proceeds |
Globe Newswire |
10/27 |
07:50 |
| Meet Patel's Passion Farms Reports 20% Year-Over-Year Growth Across Multi-State Operations |
Globe Newswire |
10/27 |
07:34 |
| InflaRx Announces November Investor Events |
Globe Newswire |
10/27 |
07:30 |
| Medicus Pharma to Present at BioFuture and Global Biotechnology Summit |
Globe Newswire |
10/27 |
07:30 |
| FTI Consulting Adds Neel Malkani to Help Private Capital Firms and Portfolio Companies Accelerate Value Creation |
Globe Newswire |
10/27 |
07:30 |
| Weatherford Announces Court Approval and Expected Closing Date for U.S. Redomestication |
Globe Newswire |
10/27 |
07:30 |
| Norwood Financial Corp announces Third Quarter Financial Results |
Globe Newswire |
10/27 |
07:30 |
| Hubbell Reports Third Quarter 2026 Results |
Globe Newswire |
10/27 |
07:30 |
| Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution |
Globe Newswire |
10/27 |
07:30 |
| Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference |
Globe Newswire |
10/27 |
07:30 |
| Lahontan Gold Provides Corporate Update on Santa Fe and West Santa Fe Drill Programs |
Globe Newswire |
10/27 |
07:30 |
| Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET |
Globe Newswire |
10/27 |
07:30 |
| Watsco Reports Record Third Quarter Sales, Strong Cash Flow and Improving Demand |
Globe Newswire |
10/27 |
07:30 |
| Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
10/27 |
07:30 |
| OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel |
Globe Newswire |
10/27 |
07:30 |
| Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK® |
Globe Newswire |
10/27 |
07:30 |
| Lumion Highlights AI Agents for After-Hours Inquiries and Lead Follow-Up |
Globe Newswire |
10/27 |
07:19 |
| German court rejects bid to end Ukrainian ex-officer's trial over Nord Stream pipeline blasts |
AP Online |
10/27 |
07:15 |
| Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131 |
Globe Newswire |
10/27 |
07:15 |
| Flow Capital Announces Trading Symbol Change to “FLOW” |
Globe Newswire |
10/27 |
07:15 |
| AI Readiness Drives Organizational Impact |
Globe Newswire |
10/27 |
07:13 |
| RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska |
Globe Newswire |
10/27 |
07:12 |
| Manual Links Marks Five Years as a Manual Link Building Service, With More Than 300 SaaS and Healthcare Brands Served |
Globe Newswire |
10/27 |
07:00 |
| Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026 |
Globe Newswire |
10/27 |
07:00 |
| Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET |
Globe Newswire |
10/27 |
07:00 |